125 related items for PubMed ID: 10469004
1. Toward better treatment of congenital adrenal hyperplasia.
Speiser PW.
Clin Endocrinol (Oxf); 1999 Sep; 51(3):273-4. PubMed ID: 10469004
[No Abstract] [Full Text] [Related]
2. Effect of carbenoxolone on the plasma renin activity and hypothalamic-pituitary-adrenal axis in congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Irony I, Cutler GB.
Clin Endocrinol (Oxf); 1999 Sep; 51(3):285-91. PubMed ID: 10469007
[Abstract] [Full Text] [Related]
3. Carbenoxolone effects in congenital adrenal hyperplasia.
Walker BR, Stewart PM.
Clin Endocrinol (Oxf); 2000 Feb; 52(2):246-8. PubMed ID: 10671957
[No Abstract] [Full Text] [Related]
4. Requirement of mineralocorticoid in congenital adrenal hyperplasia due to 11 beta-hydroxylase deficiency.
Hochberg Z, Benderly A, Kahana L, Zadik Z.
J Clin Endocrinol Metab; 1986 Jul; 63(1):36-40. PubMed ID: 3011843
[Abstract] [Full Text] [Related]
5. Failure of cortisone acetate treatment in congenital adrenal hyperplasia because of defective 11beta-hydroxysteroid dehydrogenase reductase activity.
Nordenström A, Marcus C, Axelson M, Wedell A, Ritzén EM.
J Clin Endocrinol Metab; 1999 Apr; 84(4):1210-3. PubMed ID: 10199755
[Abstract] [Full Text] [Related]
6. Liquorice, growth retardation and Addison's disease.
Doeker BM, Andler W.
Horm Res; 1999 Apr; 52(5):253-5. PubMed ID: 10844416
[Abstract] [Full Text] [Related]
7. Early hypertension and prolonged mineralocorticoid therapy discontinuation in a child with salt-wasting 21-hydroxylase deficiency.
Wasniewska M, Valenzise M, Aversa T, Mirabelli S, De Luca F, De Luca FL, Lombardo F.
J Endocrinol Invest; 2011 Feb; 34(2):159-61. PubMed ID: 21502797
[No Abstract] [Full Text] [Related]
8. [Adrenogenital syndrome].
Fujieda K.
Nihon Rinsho; 2006 Jun 28; Suppl 2():643-6. PubMed ID: 16817483
[No Abstract] [Full Text] [Related]
9. Licorice, computer-based analyses of dehydrogenase sequences, and the regulation of steroid and prostaglandin action.
Baker ME, Fanestil DD.
Mol Cell Endocrinol; 1991 Jun 28; 78(1-2):C99-102. PubMed ID: 1834493
[No Abstract] [Full Text] [Related]
10. Effects of the 11 beta-hydroxysteroid dehydrogenase inhibitor carbenoxolone on insulin sensitivity in men with type 2 diabetes.
Andrews RC, Rooyackers O, Walker BR.
J Clin Endocrinol Metab; 2003 Jan 28; 88(1):285-91. PubMed ID: 12519867
[Abstract] [Full Text] [Related]
11. Renal inactivation, mineralocorticoid generation, and 11beta-hydroxysteroid dehydrogenase inhibition ameliorate the antimineralocorticoid effect of progesterone in vivo.
Quinkler M, Meyer B, Oelkers W, Diederich S.
J Clin Endocrinol Metab; 2003 Aug 28; 88(8):3767-72. PubMed ID: 12915667
[Abstract] [Full Text] [Related]
12. [Somatic development in a group of 59 children with congenital adrenal hyperplasia in relation to therapy].
Lisá L.
Cesk Pediatr; 1989 Dec 28; 44(12):712-3. PubMed ID: 2636554
[Abstract] [Full Text] [Related]
13. The effect of carbenoxolone on the peripheral metabolism of cortisol in human patients.
Ulick S, Wang JZ, Hanukoglu A, Rösler A.
J Lab Clin Med; 1993 Dec 28; 122(6):673-6. PubMed ID: 8245686
[Abstract] [Full Text] [Related]
14. Congenital adrenal hyperplasia.
Speiser PW, White PC.
N Engl J Med; 2003 Aug 21; 349(8):776-88. PubMed ID: 12930931
[No Abstract] [Full Text] [Related]
15. New approaches to the treatment of congenital adrenal hyperplasia.
Merke DP, Cutler GB.
JAMA; 1997 Apr 02; 277(13):1073-6. PubMed ID: 9091697
[No Abstract] [Full Text] [Related]
16. [Lipoid adrenal hyperplasia].
Fujieda K.
Nihon Rinsho; 2006 May 28; Suppl 1():692-5. PubMed ID: 16776250
[No Abstract] [Full Text] [Related]
17. Inhibition of renal 11beta-hydroxysteroid dehydrogenase in vivo by carbenoxolone in the rat and its relationship to sodium excretion.
Sewell KJ, Shirley DG, Michael AE, Thompson A, Norgate DP, Unwin RJ.
Clin Sci (Lond); 1998 Oct 28; 95(4):435-43. PubMed ID: 9748419
[Abstract] [Full Text] [Related]
18. Cortisol as mineralocorticoid.
Ulick S.
J Clin Endocrinol Metab; 1996 Apr 28; 81(4):1307-8. PubMed ID: 8636321
[No Abstract] [Full Text] [Related]
19. Mineralocorticoid activity of liquorice: 11-beta-hydroxysteroid dehydrogenase deficiency comes of age.
Stewart PM, Wallace AM, Valentino R, Burt D, Shackleton CH, Edwards CR.
Lancet; 1987 Oct 10; 2(8563):821-4. PubMed ID: 2889032
[Abstract] [Full Text] [Related]
20. [3Beta-hydroxysteroid dehydrogenase deficiency].
Goto Y, Yanase T.
Nihon Rinsho; 2006 May 28; Suppl 1():685-8. PubMed ID: 16776248
[No Abstract] [Full Text] [Related]
Page: [Next] [New Search]
